Research News and Research

RSS

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

BioClinica™, Inc.,, a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.

From Clario 5 Mar 2010

Report finds public health funding is lagging as states cut back, federal programs remain flat

In a year when flagging state and local economies forced major cuts in public health spending, federal grants for disease prevention and emergency preparedness failed to fill the breach, according to a new report from The Robert Wood Johnson Foundation and the Trust for America's Health, which advocate for increased health spending.

5 Mar 2010

Risk of MS increases by many folds following infection with EBV: Study

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV).

5 Mar 2010

Sebelius meets with insurance execs, challenges them to be transparent

Reuters: During a meeting today, Health and Human Services Secretary Kathleen Sebelius pressed the CEOs of some of the nation's largest health insurers about increases in insurance premiums. "The meeting added more uncertainty for an industry that has already become Democrats' top target in their bid to overhaul the nation's healthcare system, and shares of health insurers continued to fall in late-morning trading."

5 Mar 2010

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte’s lead regenerative medicine product using Xcellerex’s XDR single use bioreactor system in its FlexFactory®. Humacyte’s product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.

5 Mar 2010

Kyto Biopharma signs licensing agreement with RFSUNY, gains patent rights to Transcobalamin Receptor

Kyto Biopharma Inc., is pleased to announce that it has signed a licensing agreement with the Research Foundation of the State University of New York. The licensing agreement grants Kyto patent rights to the Transcobalamin (Vitamin B12) Receptor and to an additional broad group of other patents which are critical to Kyto’s research and development strategy for the treatment of cancer.

5 Mar 2010

The White House full court press on health care

Reuters: President Obama is holding "two meetings with Democratic legislators at the White House on Thursday as he pushes for a vote this month on his healthcare overall plan." The first, which was scheduled for 1:30 p.m. EST, "is expected to include 11 left-leaning members and leaders of minority groups in the House of Representatives, a White House spokesman said." The second meeting "is with leaders of the New Democrat Coalition, a group of centrist Democrats. Seven U.S. representatives are expected to attend that meeting" (Zengerle, 3/4).

5 Mar 2010

Some small businesses see burden in 'Cadillac' tax

Kaiser Health News staff writer Jenny Gold, in collaboration with NPR, writes about this proposed tax. It could make it more difficult for small businesses to purchase health coverage.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

Sebelius takes on health insurers

The Wall Street Journal/Dow Jones: When health insurance executives meet with Health and Human Services Secretary Kathleen Sebelius at the White House Thursday to discuss premiums, they will "face a regulator who is well-versed in the complexities of the industry." Sebelius, whose resume includes a stretch as a state insurance commissioner, "is taking aim at rising premium rates as she joins President Barack Obama's push for an overhaul of the nation's health-coverage laws.

5 Mar 2010

Toxicologists, environmental health scientists to discuss on safeguarding public health at SOT meeting

The government's leading toxicologists and environmental health scientists will share their latest scientific accomplishments, offer continuing education courses, discuss funding and training opportunities, receive input on future research priorities, and more, at the Society of Toxicology annual meeting.

5 Mar 2010

Argos Therapeutics' AGS-004 immunotherapy for HIV demonstrates clinical and commercial potential

Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company’s Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient’s unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).

5 Mar 2010

Isotechnika Pharma receives grant of $237,069 to support NICAM program

Isotechnika Pharma Inc. today announced that it has received funding approval from the National Research Council's Industrial Research Assistance Program (IRAP) for its Non-Immunosuppressive Cyclosporin Analog Molecules (NICAM) program.

5 Mar 2010

Study shows link between Vitamin D levels and basal cell carcinoma

A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.

5 Mar 2010

Abortion language in health care bills continues to rankle both sides

"Pro-life advocates say the Democrats' health care bill would send millions of dollars to community health care centers without restrictions to keep the money from being used to fund abortions, potentially expanding access to the procedure." The National Right to Life Group "calls the Senate bill, which could come up for a vote in the House, 'the most pro-abortion piece of legislation to come before the House of Representatives.'"

5 Mar 2010

Study: Genetic variant of LTA4H offers protection against TB and leprosy

A study into why some people are more resistant than others to diseases such as tuberculosis (TB) and leprosy has identified a new genetic variant which affects susceptibility to these diseases. The findings, published today in the journal Cell, may have implications for future treatments for the two conditions.

5 Mar 2010

Obama pushes reconciliation, action on health care overhaul

In his White House speech Wednesday afternoon, President Barack Obama outlined his updated health overhaul plan and endorsed a legislative maneuver meant to move the congressional efforts on health care reform forward.

4 Mar 2010

Heartburn drug Kapidex to be marketed under new name Dexilant

The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant.

4 Mar 2010

Scientists discover genetic cause of Quebec Platelet Disorder

For some Canadians, any cut such as from dental work or surgery can cause days or more of bleeding. Although they are not hemophiliacs, for some an ordinary bruise can balloon into the size of an orange.

4 Mar 2010

Political heat tests the President's calm composure

The Washington Post: For a president "who so famously rejects drama," recent times have marked "one of the wildest policitcal stretches in recent memory." President Obama has said during yesterday's White House speech that, at stake in this legislative struggle is the nation's ability not only to solve health care problems, but "our ability to solve any problem."

4 Mar 2010